These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 8995420
1. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. Korzus E, Nagase H, Rydell R, Travis J. J Biol Chem; 1997 Jan 10; 272(2):1188-96. PubMed ID: 8995420 [Abstract] [Full Text] [Related]
2. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. Li WQ, Dehnade F, Zafarullah M. J Immunol; 2001 Mar 01; 166(5):3491-8. PubMed ID: 11207308 [Abstract] [Full Text] [Related]
3. Differential activation of the extracellular signal-regulated kinase, Jun kinase and Janus kinase-Stat pathways by oncostatin M and basic fibroblast growth factor in AIDS-derived Kaposi's sarcoma cells. Faris M, Ensoli B, Stahl N, Yancopoulos G, Nguyen A, Wang S, Nel AE. AIDS; 1996 Apr 01; 10(4):369-78. PubMed ID: 8728040 [Abstract] [Full Text] [Related]
4. Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter. Bugno M, Graeve L, Gatsios P, Koj A, Heinrich PC, Travis J, Kordula T. Nucleic Acids Res; 1995 Dec 25; 23(24):5041-7. PubMed ID: 8559663 [Abstract] [Full Text] [Related]
5. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells. Halfter H, Postert C, Friedrich M, Ringelstein EB, Stögbauer F. Brain Res Mol Brain Res; 2000 Sep 15; 80(2):198-206. PubMed ID: 11038252 [Abstract] [Full Text] [Related]
6. Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway. Stancato LF, Sakatsume M, David M, Dent P, Dong F, Petricoin EF, Krolewski JJ, Silvennoinen O, Saharinen P, Pierce J, Marshall CJ, Sturgill T, Finbloom DS, Larner AC. Mol Cell Biol; 1997 Jul 15; 17(7):3833-40. PubMed ID: 9199317 [Abstract] [Full Text] [Related]
7. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells. Halfter H, Friedrich M, Postert C, Ringelstein EB, Stögbauer F. Mol Cell Biol Res Commun; 1999 May 15; 1(2):109-16. PubMed ID: 10356359 [Abstract] [Full Text] [Related]
8. Oncostatin M differentially regulates tissue inhibitors of metalloproteinases TIMP-1 and TIMP-3 gene expression in human synovial lining cells. Gatsios P, Haubeck HD, Van de Leur E, Frisch W, Apte SS, Greiling H, Heinrich PC, Graeve L. Eur J Biochem; 1996 Oct 01; 241(1):56-63. PubMed ID: 8898888 [Abstract] [Full Text] [Related]
9. Activation of Raf-1 by interferon gamma and oncostatin M requires expression of the Stat1 transcription factor. Stancato LF, Yu CR, Petricoin EF, Larner AC. J Biol Chem; 1998 Jul 24; 273(30):18701-4. PubMed ID: 9668040 [Abstract] [Full Text] [Related]
14. Signaling pathways implicated in oncostatin M-induced aggrecanase-1 and matrix metalloproteinase-13 expression in human articular chondrocytes. El Mabrouk M, Sylvester J, Zafarullah M. Biochim Biophys Acta; 2007 Mar 24; 1773(3):309-20. PubMed ID: 17208315 [Abstract] [Full Text] [Related]
15. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA. Terstegen L, Maassen BG, Radtke S, Behrmann I, Schaper F, Heinrich PC, Graeve L, Gatsios P. FEBS Lett; 2000 Jul 28; 478(1-2):100-4. PubMed ID: 10922477 [Abstract] [Full Text] [Related]
16. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells. Nagata T, Kai H, Shibata R, Koga M, Yoshimura A, Imaizumi T. Arterioscler Thromb Vasc Biol; 2003 Apr 01; 23(4):588-93. PubMed ID: 12615664 [Abstract] [Full Text] [Related]
18. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130. Hermanns HM, Radtke S, Haan C, Schmitz-Van de Leur H, Tavernier J, Heinrich PC, Behrmann I. J Immunol; 1999 Dec 15; 163(12):6651-8. PubMed ID: 10586060 [Abstract] [Full Text] [Related]